Home » Topics » Regulatory

Regulatory
RSS

Schering-Plough seeks additional FDA approval for Rebetol capsules

Dec. 18, 2000

FDA approves pediatric indication for Tamiflu

Dec. 18, 2000

FDA clears new dose of Concerta for ADHD

Dec. 18, 2000

ODAC unanimously recommends approval of Femara as first-line breast cancer treatment

Dec. 15, 2000

New Claritin formulation receives FDA marketing approval

Dec. 14, 2000

FDA approves second indication for Antizol

Dec. 13, 2000

Galenic formulations of antithrombotic agents for s.c. administration

Dec. 12, 2000

FDA approves new indications for Prevacid

Dec. 12, 2000

Health Canada approves Asmanex Twisthaler for treatment of asthma

Dec. 12, 2000

Myobloc is first FDA-approved treatment for cervical dystonia

Dec. 11, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...